Janus Henderson Investors US’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
SGA
WP
Janus Henderson Investors US's CLB Position: Q1 2017 in Review
Janus Henderson Investors US reduced its Core Laboratories (CLB) stake by 84% in Q1 2017, selling an estimated $6.42M and leaving 10,282 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #983.
Janus Henderson Investors US first reported a position in CLB in Q2 2013 and has held it in 16 quarters since. The position peaked at $140M in Q1 2014. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.
- Janus Henderson Investors US held 10,282 shares of Core Laboratories worth $1.19M as of Q1 2017.
- Janus Henderson Investors US sold 55,200 Core Laboratories shares in Q1 2017, an estimated $6.42M.
- Core Laboratories made up ﹤0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #983 holding.
- Janus Henderson Investors US first reported a position in Core Laboratories in Q2 2013 and has held it in 16 quarters since.
- Janus Henderson Investors US's Core Laboratories position peaked at $140M in Q1 2014.
- 360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.
Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.